122 related articles for article (PubMed ID: 1133824)
1. 3-Substituted 2',3'-dihydroestra-1,3,5(10)-trieno (16alpha, 17alpha-b)furan-17beta-ols as potential estrogens.
Dinner A; Bishara RH; Rutherford BS
J Med Chem; 1975 Mar; 18(3):314-5. PubMed ID: 1133824
[TBL] [Abstract][Full Text] [Related]
2. Disteroidyl ethers. 1. Synthesis and oral long-lasting uterotrophic activity of 1,3,5(10)-estratrien-17-yl enol ethers of 3-keto steroids.
Vitali R; Gladiali S; Falconi G; Celasco G; Saccani MA; Gardi R
J Med Chem; 1977 Mar; 20(3):359-64. PubMed ID: 845869
[No Abstract] [Full Text] [Related]
3. Estradiol-16alpha-carboxylic acid esters as locally active estrogens.
Labaree DC; Reynolds TY; Hochberg RB
J Med Chem; 2001 May; 44(11):1802-14. PubMed ID: 11356114
[TBL] [Abstract][Full Text] [Related]
4. Oxidation of furans. 3. Estrogenic properties of lactones and anhydrides derived from the oxidation of 17alpha-[3-furyl]estradiol derivatives.
Lefebvre Y; Revesz C
J Med Chem; 1975 Jun; 18(6):581-3. PubMed ID: 1151972
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant and estrogenic effects of two new 17 beta-aminoestrogens, butolame [17 beta-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17 beta-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol].
Lemini C; Rubio-Póo C; Silva G; García-Mondragón J; Zavala E; Mendoza-Patiño N; Castro D; Cruz-Almanza R; Mandoki JJ
Steroids; 1993 Oct; 58(10):457-61. PubMed ID: 8256254
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
[TBL] [Abstract][Full Text] [Related]
7. [Experimental studies of the estrogenic and anti-estrogenic effects of 17alpha-thiocyanomethyl-17beta-tetrahydropyranyloxyestra-1,3,5(10)-triene-3-methyl ether and 17beta-phenylaminocarbonylestra-1,3,5(10)-triene-3-methyl ether].
Strecke J; Ivanenko T; Fedotow V; Schwetzow J
Pharmazie; 1977 Oct; 32(10):598-602. PubMed ID: 607220
[No Abstract] [Full Text] [Related]
8. Estrogenic effects of 17 beta-aminoestrogens assessed in uteri of rats and mice.
Lemini C; Franco Y; Avila ME; Jaimez R
Eur J Pharmacol; 2005 Mar; 510(3):235-9. PubMed ID: 15763248
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of two new radiolabelled estrogens: [125I](E)-3-methoxy-17alpha-iodovinylestra-1,3,5(10),6-tetraen-17beta-ol and.
Melo e Silva MC; Patrćio L; Gano L; Sá e Melo ML; Inohae E; Mataka S; Thiemann T
Appl Radiat Isot; 2001 Feb; 54(2):227-39. PubMed ID: 11200884
[TBL] [Abstract][Full Text] [Related]
10. B-ring unsaturated estrogens: biological evaluation of 17alpha-Dihydroequilein and novel B-Nor-6-thiaequilenins as tissue selective estrogens.
Lugar CW; Magee D; Adrian MD; Shetler P; Bryant HU; Dodge JA
Bioorg Med Chem Lett; 2003 Dec; 13(24):4281-4. PubMed ID: 14643309
[TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of the dissociation rate between the vaginotrophic and uterotrphic activities of 1-hydroxy-1, 3, 5 (10)-estratriene derivatives with natural and unnatural configuration at C8 using ovariectomized mice.
Nishino Y; Neumann F; Prezewowsky K; Wiechert R
Steroids; 1976 Sep; 28(3):325-57. PubMed ID: 982491
[TBL] [Abstract][Full Text] [Related]
12. THE ESTROGENIC ACTIVITIES OF 16-ALPHA, 17-ALPHA- AND 16-BETA, 17-BETA- EPOXY-1,3,5(10)-ESTRATRIENE-3-OL.
MAY M; JOHNSON BJ; TRIGGLE DJ; DANIELLI JF; GILANI SS
Life Sci (1962); 1965 Mar; 4():705-11. PubMed ID: 14330455
[No Abstract] [Full Text] [Related]
13. Anti-uterotropic activities of 16beta-ethyl-1,3,5(10)-estratrien-3,17beta-diol(16beta-ethylestradiol-17beta) and related compounds.
Takikawa H
Chem Pharm Bull (Tokyo); 1977 Mar; 25(3):501-3. PubMed ID: 872283
[No Abstract] [Full Text] [Related]
14. Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens.
Miller CP; Collini MD; Tran BD; Harris HA; Kharode YP; Marzolf JT; Moran RA; Henderson RA; Bender RH; Unwalla RJ; Greenberger LM; Yardley JP; Abou-Gharbia MA; Lyttle CR; Komm BS
J Med Chem; 2001 May; 44(11):1654-7. PubMed ID: 11356100
[No Abstract] [Full Text] [Related]
15. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase.
Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D
Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological properties of 17 alpha-furylestradiol and dihydroequilin derivatives.
Revesz C; Lefebvre Y
J Med Chem; 1975 Feb; 18(2):217-9. PubMed ID: 1120993
[TBL] [Abstract][Full Text] [Related]
17. Preparation of 14,15-secoestra-1,3,5(10)-trien-15-ynes, inhibitors of estradiol dehydrogenase.
Auchus RJ; Palmer JO; Carrell HL; Covey DF
Steroids; 1989; 53(1-2):77-96. PubMed ID: 2772972
[TBL] [Abstract][Full Text] [Related]
18. The effect of raloxifene on the uterine weight response in immature mice exposed to 17beta-estradiol, 1,1,1-trichloro-2, 2-bis(p-chlorophenyl)ethane, and methoxychlor.
Al-Jamal JH; Dubin NH
Am J Obstet Gynecol; 2000 May; 182(5):1099-102. PubMed ID: 10819839
[TBL] [Abstract][Full Text] [Related]
19. Synthetic estrogen 17alpha-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17beta-estradiol.
Hyder SM; Chiappetta C; Stancel GM
J Pharmacol Exp Ther; 1999 Aug; 290(2):740-7. PubMed ID: 10411586
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure, and screening of estrogenic and antiestrogenic activity of new 3,17-substituted-16,17-seco-estratriene derivatives.
Jovanović-Santa S; Petrović J; Andrić S; Kovacević R; Durendić E; Sakac M; Lazar D; Stanković S
Bioorg Chem; 2003 Dec; 31(6):475-84. PubMed ID: 14613768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
